Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arteris (AIP) EBITDA (2023 - 2026)

Arteris filings provide 4 years of EBITDA readings, the most recent being -$9.3 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 14.43% to -$9.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$34.7 million, a 11.52% decrease, with the full-year FY2025 number at -$33.1 million, down 4.88% from a year prior.
  • EBITDA hit -$9.3 million in Q1 2026 for Arteris, down from -$8.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$7.1 million in Q4 2024 to a low of -$10.5 million in Q4 2023.
  • Median EBITDA over the past 4 years was -$8.5 million (2025), compared with a mean of -$8.6 million.
  • Biggest five-year swings in EBITDA: skyrocketed 32.15% in 2024 and later dropped 19.22% in 2025.
  • Arteris' EBITDA stood at -$10.5 million in 2023, then skyrocketed by 32.15% to -$7.1 million in 2024, then dropped by 19.22% to -$8.5 million in 2025, then fell by 9.84% to -$9.3 million in 2026.
  • The last three reported values for EBITDA were -$9.3 million (Q1 2026), -$8.5 million (Q4 2025), and -$8.7 million (Q3 2025) per Business Quant data.